“…Recent systematic reviews and observational studies highlight the relevance of socio-cultural determinants on adherence to pharmacotherapy among patients living with NCDs ( Dhar et al, 2017 ; Niriayo et al, 2018 ; Swihart et al, 2018 ; Shahin et al, 2019 ; Al-Ganmi et al, 2020 ; Park et al, 2020 ; Raza et al, 2020 ; Świątoniowska-Lonc et al, 2021 ); however, the dearth of published literature suggests such awareness in pharmacovigilance processes is yet to be realized. Although poor adherence to pharmacotherapy is a common predictor of adverse drug reactions; the converse is also true ( Gellad et al, 2011 ; Adem et al, 2021 ; Elangwe et al, 2020 ) and therefore enriching pharmacovigilance processes with what is referred to as ‘the patient’s voice’ may facilitate causality analysis of adverse drug reactions ( Simon et al, 2020 ).…”